<DOC>
	<DOCNO>NCT02897414</DOCNO>
	<brief_summary>In April 2011 , U.S. Food Drug Administration ( FDA ) determine class-wide risk evaluation mitigation strategy ( REMS ) extended-release ( ER ) long-acting ( LA ) opioid medication necessary support national effort reduce serious adverse outcome result opioid abuse . This study evaluate trend ER/LA REMS implementation change mortality rate associate prescription opioids utilize state medical examiner databases multiple state . Databases 2005 recent year available obtain .</brief_summary>
	<brief_title>ER/LA Opioid Analgesics - Surveillance Monitoring State Medical Examiner Databases</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Fatalities associate prescription opioids several state 20052015 ( later ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>